a 2020

The Outcomes-based Risk Sharing Model for Targeted Drugs Based on the Czech National Register of Reimbursed Health Services

ŘÍHOVÁ, Barbora, Klára BENEŠOVÁ, Jiří JARKOVSKÝ and Regina DEMLOVÁ

Basic information

Original name

The Outcomes-based Risk Sharing Model for Targeted Drugs Based on the Czech National Register of Reimbursed Health Services

Authors

ŘÍHOVÁ, Barbora (203 Czech Republic, guarantor, belonging to the institution), Klára BENEŠOVÁ (203 Czech Republic, belonging to the institution), Jiří JARKOVSKÝ (203 Czech Republic, belonging to the institution) and Regina DEMLOVÁ (203 Czech Republic, belonging to the institution)

Edition

2020

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 5.725

RIV identification code

RIV/00216224:14110/20:00118141

Organization unit

Faculty of Medicine

ISSN

Keywords in English

Risk Sharing Model; Targeted Drug

Tags

International impact, Reviewed
Změněno: 24/3/2021 08:41, Mgr. Tereza Miškechová

Abstract

V originále

In the outcome-based risk sharing agreements (OBRSA), performance in a defined patient population is tracked over a specified period of time at the individual patient level and the amount or level of reimbursement is determined on the basis of the outcomes achieved. We applied OBRSA models to the national level data of two targeted drugs reimbursed in the Czech Republic.

Links

LM2018128, research and development project
Name: Český národní uzel Evropské sítě infrastruktur klinického výzkumu (Acronym: CZECRIN)
Investor: Ministry of Education, Youth and Sports of the CR